Can Sequential Coagulation Monitoring Predict Major Haemorrhage in Extremely Low Birth Weight Infants?

Margarita Thanhaeuser; Christoph Binder; Ulla Derhaschnig; Bernd Jilma; Margit Kornsteiner-Krenn; Mercedes Huber-Dangl; Andreas Repa; Alexandra Kreissl; Angelika Berger; Nadja Haiden

doi:10.1055/s-0038-1655744

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2018; 118(07): 1185-1193
DOI: 10.1055/s-0038-1655744

Coagulation and Fibrinolysis

Georg Thieme Verlag KG Stuttgart · New York

Can Sequential Coagulation Monitoring Predict Major Haemorrhage in Extremely Low Birth Weight Infants?

Margarita Thanhaeuser

¹Division of Neonatology, Pediatric Intensive Care Medicine and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria

,

Christoph Binder

¹Division of Neonatology, Pediatric Intensive Care Medicine and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria

,

Ulla Derhaschnig

²Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria

³Department of Emergency Medicine, Medical University of Vienna, Vienna, Austria

,

Bernd Jilma

²Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria

,

Margit Kornsteiner-Krenn

¹Division of Neonatology, Pediatric Intensive Care Medicine and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria

,

Mercedes Huber-Dangl

¹Division of Neonatology, Pediatric Intensive Care Medicine and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria

,

Andreas Repa

¹Division of Neonatology, Pediatric Intensive Care Medicine and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria

,

Alexandra Kreissl

¹Division of Neonatology, Pediatric Intensive Care Medicine and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria

,

Angelika Berger

¹Division of Neonatology, Pediatric Intensive Care Medicine and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria

,

Nadja Haiden

¹Division of Neonatology, Pediatric Intensive Care Medicine and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria

› Author Affiliations

Abstract

Introduction Bleeds such as intra-ventricular (IVH) and pulmonary haemorrhage (PH) are life-threatening events in extremely low birth weight (ELBW) infants. Serial coagulation monitoring by measuring the international normalized ratio (INR) with small volume samples might facilitate early diagnosis and possibly prevent major bleeds.

Materials and Methods This was a prospective longitudinal study performed in ELBW infants, who received serial INR monitoring by point of care testing during their first 30 days of life. The primary objective was to explore whether INR monitoring could predict major bleeding events (IVH, PH). Secondary objectives were mortality and feasibility in this patient population.

Results A total of 127 ELBW infants were stratified into a bleeding and a non-bleeding group. Bleeding events occurred in 31% (39/127) of the infants, whereupon 24% developed IVH and 9% PH. Infants in the bleeding group were 4 days younger at birth (p = 0.05) and had a substantially higher mortality rate of 26% versus 5% in controls (p = 0.005). Median INR during the first 3 days before a bleeding event was 1.55 (95% confidence interval [CI]: 1.39–1.74) compared with the control group with 1.45 (95% CI: 1.44–1.58; p = 0.81). Platelet counts were significantly lower in the bleeding group on the 3rd day and during the 2nd to 4th week of life.

Discussion Serial coagulation monitoring by an INR point of care testing is feasible in ELBW infants but could not predict bleeding events. Further studies with daily monitoring of INR and platelet counts during the first days of life might be able to more precisely detect a risk of major haemorrhage in ELBW infants.

Keywords

coagulation monitoring - intra-ventricular haemorrhage - pulmonary haemorrhage - premature infant

Full Text

References

References
1 Bolisetty S, Dhawan A, Abdel-Latif M, Bajuk B, Stack J, Lui K. ; New South Wales and Australian Capital Territory Neonatal Intensive Care Units' Data Collection. Intraventricular hemorrhage and neurodevelopmental outcomes in extreme preterm infants. Pediatrics 2014; 133 (01) 55-62
2 McCrea HJ, Ment LR. The diagnosis, management, and postnatal prevention of intraventricular hemorrhage in the preterm neonate. Clin Perinatol 2008; 35 (04) 777-792
3 Ferreira CH, Carmona F, Martinez FE. Prevalence, risk factors and outcomes associated with pulmonary hemorrhage in newborns. J Pediatr (Rio J) 2014; 90 (03) 316-322
4 Chen YY, Wang HP, Lin SM. , et al; Taiwan Premature Infant Development Collaborative Study Group. Pulmonary hemorrhage in very low-birthweight infants: risk factors and management. Pediatr Int 2012; 54 (06) 743-747
5 Pal S, Curley A, Stanworth SJ. Interpretation of clotting tests in the neonate. Arch Dis Child Fetal Neonatal Ed 2015; 100 (03) F270-F274
6 Neary E, McCallion N, Kevane B. , et al. Coagulation indices in very preterm infants from cord blood and postnatal samples. J Thromb Haemost 2015; 13 (11) 2021-2030
7 Mitsiakos G, Papathanasiou AE, Kyriakidis I. , et al. Intraventricular hemorrhage and platelet indices in extremely premature neonates. J Pediatr Hematol Oncol 2016; 38 (07) 533-538
8 Cvirn G, Gallistl S, Leschnik B, Muntean W. Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates. J Thromb Haemost 2003; 1 (02) 263-268
9 Dani C, Poggi C, Ceciarini F, Bertini G, Pratesi S, Rubaltelli FF. Coagulopathy screening and early plasma treatment for the prevention of intraventricular hemorrhage in preterm infants. Transfusion 2009; 49 (12) 2637-2644
10 Duppré P, Sauer H, Giannopoulou EZ. , et al. Cellular and humoral coagulation profiles and occurrence of IVH in VLBW and ELWB infants. Early Hum Dev 2015; 91 (12) 695-700
11 Tran TT, Veldman A, Malhotra A. Does risk-based coagulation screening predict intraventricular haemorrhage in extreme premature infants?. Blood Coagul Fibrinolysis 2012; 23 (06) 532-536
12 Iijima S, Baba T, Ueno D, Ohishi A. International normalized ratio testing with a point-of-care coagulometer in 1-month-old infants: a comparison with Normotest. Thromb Res 2016; 145: 72-77
13 Ruzicka K, Kapiotis S, Quehenberger P. , et al. Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguCheck Plus in various clinical settings. Thromb Res 1997; 87 (05) 431-440
14 Steurer MA, Berger TM. Massively elevated nucleated red blood cells and cerebral or pulmonary hemorrhage in severely growth-restricted infants--is there more than coincidence?. Neonatology 2008; 94 (04) 314-319
15 Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978; 92 (04) 529-534
16 Skinner JR, Boys RJ, Hunter S, Hey EN. Non-invasive assessment of pulmonary arterial pressure in healthy neonates. Arch Dis Child 1991; 66 (4 Spec No): 386-390
17 Shannon KM, Keith III JF, Mentzer WC. , et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 1995; 95 (01) 1-8
18 Bell MJ. Neonatal necrotizing enterocolitis. N Engl J Med 1978; 298 (05) 281-282
19 International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005; 123 (07) 991-999
20 Tranquilli AL, Dekker G, Magee L. , et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens 2014; 4 (02) 97-104
21 Kuperman AA, Kenet G, Papadakis E, Brenner B. Intraventricular hemorrhage in preterm infants: coagulation perspectives. Semin Thromb Hemost 2011; 37 (07) 730-736
22 Madan A, Kumar R, Adams MM, Benitz WE, Geaghan SM, Widness JA. Reduction in red blood cell transfusions using a bedside analyzer in extremely low birth weight infants. J Perinatol 2005; 25 (01) 21-25
23 Lemyre B, Sample M, Lacaze-Masmonteil T. ; Canadian Paediatric Society, Fetus and Newborn Committee. Minimizing blood loss and the need for transfusions in very premature infants. Paediatr Child Health 2015; 20 (08) 451-462
24 Woo HC, Tolosa L, El-Metwally D, Viscardi RM. Glucose monitoring in neonates: need for accurate and non-invasive methods. Arch Dis Child Fetal Neonatal Ed 2014; 99 (02) F153-F157
25 Carceller-Blanchard A, Cousineau J, Delvin EE. Point of care testing: transcutaneous bilirubinometry in neonates. Clin Biochem 2009; 42 (03) 143-149
26 Kako H, Raman VT, Tumin D, Rice J, Tobias JD. Point-of-care testing for coagulation function: CoaguChek^® XS System versus standard laboratory testing in pediatric patients with normal and abnormal coagulation function. J Anesth 2017; 31 (03) 345-350
27 Sola-Visner M, Bercovitz RS. Neonatal platelet transfusions and future areas of research. Transfus Med Rev 2016; 30 (04) 183-188
28 Greisen G, Andreasen RB. Recombinant factor VIIa in preterm neonates with prolonged prothrombin time. Blood Coagul Fibrinolysis 2003; 14 (01) 117-120
29 Poralla C, Hertfelder HJ, Oldenburg J, Müller A, Bartmann P, Heep A. Treatment of acute pulmonary haemorrhage in extremely preterm infants with recombinant activated factor VII. Acta Paediatr 2010; 99 (02) 298-300
30 Olomu N, Kulkarni R, Manco-Johnson M. Treatment of severe pulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants. J Perinatol 2002; 22 (08) 672-674
31 Piotrowski A, Dabrowska-Wojciak I, Mikinka M. , et al. Coagulation abnormalities and severe intraventricular hemorrhage in extremely low birth weight infants. J Matern Fetal Neonatal Med 2010; 23 (07) 601-606
32 Veldman A, Josef J, Fischer D, Volk WR. A prospective pilot study of prophylactic treatment of preterm neonates with recombinant activated factor VII during the first 72 hours of life. Pediatr Crit Care Med 2006; 7 (01) 34-39
33 Patel RM, Rysavy MA, Bell EF, Tyson JE. Survival of infants born at periviable gestational ages. Clin Perinatol 2017; 44 (02) 287-303
34 Dani C, Poggi C, Fontanelli G. Relationship between platelet count and volume and spontaneous and pharmacological closure of ductus arteriosus in preterm infants. Am J Perinatol 2013; 30 (05) 359-364
35 Johnson CT, Farzin A, Burd I. Current management and long-term outcomes following chorioamnionitis. Obstet Gynecol Clin North Am 2014; 41 (04) 649-669
36 Goldblum RM, Goldman AS, Garza C, Johnson CA, Nichols BL. Human milk banking. II. Relative stability of immunologic factors in stored colostrum. Acta Paediatr Scand 1982; 71 (01) 143-144